In March 2025, the company introduced new designs for the direct-to-purchaser presenting of its Wegovy weight loss drug. The company established a whole new pharmacy, referred to as NovoCare, which might cost customers $499 a month for access to the drug, lower than 50 percent the expense of the drug as a result of other pharmaceutical distribution